🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Larry Robbins’s CORZ Holdings & Trades

First Buy
Q3 2026
Duration Held
1 Quarters
Largest Add
Q3 2026
+1.59 M Shares
Current Position
1.59 M Shares
$25.37 M Value

Larry Robbins's CORZ Position Overview

Larry Robbins (via Glenview Capital Management, LLC) currently holds 1.59 M shares of Core Scientific, Inc. (CORZ) worth $25.37 M, representing 0.41% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Larry Robbins has initiated a new position in CORZ, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Larry Robbins's Core Scientific (CORZ) Holding Value Over Time

Track share changes against reported price movement

Quarterly Core Scientific (CORZ) Trades by Larry Robbins

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +1.59 M New Buy 1.59 M $15.98

Larry Robbins's Core Scientific Investment FAQs

Larry Robbins first purchased Core Scientific, Inc. (CORZ) in Q3 2026, acquiring 1,587,450 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Larry Robbins has held Core Scientific, Inc. (CORZ) for 1 quarters since Q3 2026.

Larry Robbins's largest addition to Core Scientific, Inc. (CORZ) was in Q3 2026, adding 1,587,450 shares worth $25.37 M.

According to the latest 13F filing for Q3 2026, Larry Robbins's firm, Glenview Capital Management, LLC, owns 1,587,450 shares of Core Scientific, Inc. (CORZ), valued at approximately $25.37 M.

As of the Q3 2026 filing, Core Scientific, Inc. (CORZ) represents approximately 0.41% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.

Larry Robbins's peak holding in Core Scientific, Inc. (CORZ) was 1,587,450 shares, as reported at the end of Q3 2026.